caa a22 4500 469121475 CHVBK 20180323133140.0 cr unu---uuuuu 170328e19920201xx s 000 0 eng 10.1007/BF02246256 doi (NATIONALLICENCE)springer-10.1007/BF02246256 Hetzel W. Pharma Clinical Research Department, F. Hoffmann-La Roche Ltd, CH-4002, Basel, Switzerland aut Safety of moclobemide taken in overdose for attempted suicide [Elektronische Daten] [W. Hetzel] Moclobemide is a reversible inhibitor of the monoamine oxidase type A. In clinical studies, more than 3900 patients have been treated with moclobemide for depression. Eighteen of these patients attempted suicide by overdosing moclobemide with or without other drugs. All patients recovered fully without leaving signs of cardio-or hepatotoxicity. Moclobemide can safely be prescribed for in- and out-patient treatment of depression. Springer-Verlag, 1992 Moclobemide nationallicence MAO-A inhibitor nationallicence Overdose nationallicence Psychopharmacology Springer-Verlag 106(1992-02-01), S127-S129 0033-3158 106<S127 1992 106 213 https://doi.org/10.1007/BF02246256 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF02246256 text/html Onlinezugriff via DOI NATIONALLICENCE 100 1- Hetzel W. Pharma Clinical Research Department, F. Hoffmann-La Roche Ltd, CH-4002, Basel, Switzerland aut NATIONALLICENCE 773 0- Psychopharmacology Springer-Verlag 106(1992-02-01), S127-S129 0033-3158 106<S127 1992 106 213 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer